Found: 5
Select item for more details and to access through your institution.
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
- Published in:
- Pituitary, 2023, v. 26, n. 1, p. 57, doi. 10.1007/s11102-022-01283-3
- By:
- Publication type:
- Article
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.
- Published in:
- Pituitary, 2021, v. 24, n. 4, p. 611, doi. 10.1007/s11102-021-01138-3
- By:
- Publication type:
- Article
Shared Decision-Making in Growth Hormone Therapy—Implications for Patient Care.
- Published in:
- Frontiers in Endocrinology, 2018, p. N.PAG, doi. 10.3389/fendo.2018.00688
- By:
- Publication type:
- Article
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 6, p. 1, doi. 10.1210/jendso/bvad054
- By:
- Publication type:
- Article
Differential diagnosis and management of abnormal uterine bleeding due to hyperprolactinemia.
- Published in:
- Middle East Fertility Society Journal, 2016, v. 21, n. 3, p. 137, doi. 10.1016/j.mefs.2016.02.001
- By:
- Publication type:
- Article